• 1
    Fass R, Fennerty M, Vakil N. Nonerosive reflux disease – current concepts and dilemmas. Am J Gastroenterol 1996; 96: 30314.
  • 2
    Locke G 3rd, Talley N, Fett S, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Omsted Country, Minnesota. Gastroenterology 1997; 112: 144856.
  • 3
    Carlsson R, Galmiche J, Dent J, et al. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a metanalysis of long-term omeprazole trials. Aliment Pharmacol Ther 1997; 11: 47382.
  • 4
    Richardson P, Hawkey C, Stack W. Proton pump inhibitors: pharmacology and rationale for use in gastrointestinal disorders. Drugs 1998; 56: 30735.
  • 5
    Fass R, Murthy U, Hayden C, et al. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy – a prospective, randomized multi-centre study. Aliment Pharmacol Ther 2000; 14: 1595603.
  • 6
    Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next? Aliment Pharmacol Ther 2006; 23: 128.
  • 7
    Vela M, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastro-oesophageal reflux: effect of omeprazole. Gastroenterology 2001; 120: 1599606.
  • 8
    Tack J, Koek G, Demedts I, et al. Gastro-oesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett’s oesophagus: acid reflux, bile reflux, or both? Am J Gastroenterol 2004; 99: 9818.
    Direct Link:
  • 9
    Lind T, Havelund T, Carlsson R, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 9749.
  • 10
    Hayden C, Bernstein C, Hall R, et al. Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD). Dig Dis Sci 2002; 47: 18.
  • 11
    Diehl D. Acupuncture for gastrointestinal and hepatobiliary disorders. J Altern Complement Med 1999; 5: 2745.
  • 12
    Samuels N. Acupuncture for nausea: how does it work? Harefuah 2003; 142: 297300.
  • 13
    Asauliuk I, Boichak M, Golik L. The combined treatment of peptic ulcer with the differentiated of nontraditional physiotherapeutic methods. Lik Sprava 1996; Oct–Dec: (1012): 119–22.
  • 14
    Sodipo J, Falaiye J. Acupuncture and gastric acid studies. Am J Chin Med 1979; 7: 35661.
  • 15
    Tougas G, Yuan L, Radamaker J, et al. Effect of acupuncture on gastric acid secretion in healthy male volunteers. Dig Dis Sci 1992; 37: 157682.
  • 16
    Xu S, Zha H, Hou X, Chen J. Electroacupuncture accelerates solid gastric empting in patients with functional dyspepsia. Gastroenterology 2004; 126: T1163.
  • 17
    Chang X, Yan J, Yi S, et al. The affects of acupuncture at sibai and neiting acupoints on gastric peristalsis. J Tradit Chin Med 2001; 21: 2868.
  • 18
    Kaada B. Successful treatment of esophageal dysmotility and Raynaud’s phenomenon in systemic sclerosis and achalasia by transcutaneous nerve stimulation. Increase in plasma VIP concentration. Scand J Gastroenterol 1987; 22: 113746.
  • 19
    Chang F, Chey W, Ouyang A. Effect of transcutaneous nerve stimulation on esophageal function in normal subjects – evidence for a somatovisceral reflex. Am J Chin Med 1996; 24: 18592.
  • 20
    Borjesson M, Pilhall M, Eliasson T, et al. Esophageal visceral pain sensitivity: effects of TENS and correlation with manometric findings. Dig Dis Sci 1998; 43: 16218.
  • 21
    Zhou L, Chey W. Electric acupuncture stimulates non-parietal cell secretion of the stomach in dog. Life Sci 1984; 34: 22338.
  • 22
    Liu L, Zhou L, Zhang D, Li J. Effects of acupuncture on antral G cells in patients with gastric disease. Zhen Ci Yan Jiu 1994; 19: 758.
  • 23
    Fass R, Fennerty M, Ofman J, et al. The clinical and economic value of a short course of omeprazole patients with noncardiac chest pain. Gastroenterology 1998; 115: 429.
  • 24
    Locke G, Galley N, Weaver A, Zinsmeister A. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 53947.
  • 25
    Ware J, Sherbourne C. The MOS 36-item short form health survey (SF-36) I. Conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 26
    Flaws B, Sionneau P. The Treatment of Modern Western Medical Diseases with Chinese Medicine. Boulder: Blue Poppy Press, 2001.
  • 27
    Maciocia G. The treatment of diseases with acupuncture and Chinese herbs. In: The Practice of Chinese Medicine: the treatment of diseases with acupuncture and Chinese herbs. New York: Churchill Livingstone, 1994; 383417.
  • 28
    Lyttleton MJ. the treatment of disease with traditional Chinese medicine. In: MacleanW, LyttletonJ, eds. Clinical Handbook of Internal Medicine. Sydney: University of Western Sydney, 2002; 11031.
  • 29
    Dedman P, Al-Khafaji M, Baker K. A Manual of Acupuncture. East Sussex: Journal of Chinese Medicine Publications, 1998.
  • 30
    Ouyang H, Chen J. Review article: therapeutic roles of acupuncture in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20: 83141.
  • 31
    Charbel S, Khandwala M, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005; 100: 2839.
    Direct Link:
  • 32
    Bautista JM, Wong WM, Pulliam G, et al. The value of ambulatory 24 hr esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications. Dig Dis Sci 2005; 50: 190915.
  • 33
    Kudara N, Chiba T, Orii S, Suzuki K. Gastric emptying of patients with persistent reflux symptoms and erosive esophagitis under PPI therapy (abstract). Neurogastroenterol Motil 2004; 16: 654.
  • 34
    Dean B, Gano A Jr, Knight K, Offman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 65664.
  • 35
    Shapiro M, Green C, Faybush EM, et al. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther 2006; 23: 3219.
  • 36
    Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain. Gut 2002; 51: 88592.
  • 37
    Lund I, Lundeberg T. Are minimal, superficial or sham acupuncture procedures acceptable as inert placebo controls? Acupunct Med 2006; 24: 135.
  • 38
    Linde K, Streng A, Jurgens S, et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA 2005; 293: 211825.
  • 39
    Furlan AD, Van Tulder MW, Cherkin DC, et al. Acupuncture and dry-needling for low back pain. Cochrane Database Syst Rev 2005; 1: CD001351.
  • 40
    Lim B, Manheimer E, Lao L, et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2006; 4: CD005111.
  • 41
    Olausson H, Lamarre Y, Backlund H, et al. Unmyelinated tactile afferents signal touch and project to insular cortex. Nat Neurosci 2002; 5: 9004.